CCI-779 (temsirolimus)

temsirolimus · Wyeth Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CCI-779 (temsirolimus), covering 2013-06-04 to 2018-06-26. Get the full timeline:

Most recent: Clinical Trial Update: CCI-779 in Treating Patients With Malignant Glioma [Phase 1, Phase 2]